Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - EASTGATE BIOTECH CORP | etbi_8k.htm |
EXHIBIT 16.1
May 15, 2017
Securities and Exchange Commission
100 F Street, N.W.
Washington, D.C. 20549
Re: Eastgate Biotech Corp.
We have read the statements of Eastgate Biotech Corp. pertaining to our firm included under Item 4.01 and Item 4.02 of Form 8-K dated May 10, 2017 and agree with such statements as they pertain to our firm.
/s/ Sadler, Gibb & Associates, LLC
SADLER, GIBB & ASSOCIATES, LLC
Salt Lake City, Utah
May 15, 2017